Originally discovered by the Laurie laboratory [3], several studies have revealed that the active monomeric form of Lacritin is significantly downregulated in patients suffering from chronic blepharitis [4], aqueous-deficient dry eye [5], contact-lens related dry eye [6], and dry eyes associated with primary Sjögren’s syndrome (SS) [7]. Here, LACRT is linked to dry eye syndrome.